Dieb W, Ouachikh O, Durif F, Hafidi A
Clermont Université EA7280, Neuro-psycho-pharmacologie des systèmes dopaminergiques sous-corticaux, Université d'Auvergne, Clermont-Ferrand, France.
Service de Neurologie, CHU Clermont-Ferrand, France.
Eur J Pain. 2016 Feb;20(2):196-205. doi: 10.1002/ejp.707. Epub 2015 Apr 21.
Dopamine is implicated in different orofacial pain-related diseases. The mechanisms underlying this invalidating pain are not yet understood. Therefore, the present study investigated if unilateral or bilateral lesions of the medial forebrain bundle (MFB) could induce a trigeminal static mechanical allodynia (SMA) comparable to that obtained after chronic construction injury of the infraorbital nerve (CCI-IoN) in rats.
Unilateral and bilateral nigrostriatal lesions were obtained by injecting 6-hydroxydopamine into the MFB, and peripheral lesion was obtained by CCI-IoN. Static allodynia behaviour was tested by a mild non-noxious static von Frey filament stimulus. The analgesic effects of bromocriptine (D2R agonist) were assessed by both intraperitoneal and intracisternal injections. Finally, immunohistochemical study was done to investigate the implication of the protein kinase c isoform gamma (PKCγ) and the phosphorylated form of extracellular signal-related kinase 1/2 (pERK1/2) in pain sensitization at segmental level.
6-OHDA-lesioned animals developed SMA in the orofacial region as assessed by non-noxious stimuli. Intraperitoneal and intracisternal injections of bromocriptine alleviated this allodynic behaviour. Investigations within the medullary dorsal horn revealed an increase in PKCγ expression, a protein implicated in the chronicity of pain, within superficial laminae in 6-OHDA-lesioned rats. Also static mechanical stimulations of the orofacial region evoked increased expression of the molecular pain marker pERK1/2 in 6-OHDA-lesioned rats.
Our data show that unilateral and bilateral dopamine depletion promoted trigeminal SMA comparable to that obtained after CCI-IoN. This allodynia can be alleviated by D2R activation, making D2R agonist a potential analgesic for orofacial neuropathic pain.
多巴胺与不同的口面部疼痛相关疾病有关。这种致痛的潜在机制尚不清楚。因此,本研究调查了内侧前脑束(MFB)的单侧或双侧损伤是否能诱发大鼠三叉神经静态机械性异常性疼痛(SMA),其程度与眶下神经慢性压迫损伤(CCI-IoN)后获得的程度相当。
通过向MFB注射6-羟基多巴胺获得单侧和双侧黑质纹状体损伤,通过CCI-IoN获得外周损伤。通过轻度非伤害性静态von Frey细丝刺激测试静态异常性疼痛行为。通过腹腔内和脑池内注射评估溴隐亭(D2R激动剂)的镇痛作用。最后,进行免疫组织化学研究,以调查蛋白激酶c同工型γ(PKCγ)和细胞外信号调节激酶1/2的磷酸化形式(pERK1/2)在节段水平疼痛致敏中的作用。
通过非伤害性刺激评估,6-OHDA损伤的动物在口面部区域出现了SMA。腹腔内和脑池内注射溴隐亭减轻了这种异常性疼痛行为。在延髓背角内的研究显示,在6-OHDA损伤的大鼠中,参与疼痛慢性化的蛋白PKCγ在浅层中的表达增加。此外,对口面部区域的静态机械刺激在6-OHDA损伤的大鼠中引起分子疼痛标志物pERK1/2的表达增加。
我们的数据表明,单侧和双侧多巴胺耗竭促进了与CCI-IoN后相当的三叉神经SMA。这种异常性疼痛可通过D2R激活得到缓解,使D2R激动剂成为口面部神经性疼痛的潜在镇痛药。